Form 4: IonQ Executive Chair Sells Over 4.4 Million Shares in Pre-Planned Transactions

IonQ, Inc.'s Executive Chair and Director, Peter Hume Chapman, executed pre-planned sales of over 4.4 million shares of common stock in mid-June 2025, generating approximately $171 million.

Summary

• Peter Hume Chapman, Executive Chair and Director of IonQ, Inc. (IONQ), reported significant stock transactions on June 16 and June 17, 2025.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, indicating pre-scheduled sales.
• On June 16, 2025, Mr. Chapman acquired 3,581,193 shares of common stock through the exercise of employee stock options at an exercise price of $0.1334 per share.
• Concurrently on June 16, 2025, he disposed of 3,581,193 shares of common stock at a weighted average price of $38.126 per share, with prices ranging from $36.0450 to $39.1450.
• On June 17, 2025, Mr. Chapman acquired an additional 910,740 shares of common stock via option exercise at $0.1334 per share.
• Also on June 17, 2025, he sold 910,740 shares of common stock at a weighted average price of $37.7787 per share, with prices ranging from $36.87 to $38.65.
• In total, Mr. Chapman sold 4,491,933 shares of IonQ common stock, generating approximately $171 million in proceeds.
• Following these transactions, Mr. Chapman's direct beneficial ownership of common stock is 390,329 shares, and he retains 1,604,972 employee stock options.
• All exercised options were fully vested and exercisable as of the transaction dates, with an original exercise price of $0.14 and an expiration date of May 16, 2029.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the significant volume of insider selling by a key executive. However, this is mitigated by the fact that the sales were pre-planned under a Rule 10b5-1 plan, which suggests they were not based on new, adverse information.

Positives

• The transactions were executed under a Rule 10b5-1 trading plan, which suggests the sales were pre-scheduled and not based on new, non-public negative information about the company.
• The high sale prices (weighted averages of $38.126 and $37.7787) indicate a favorable market valuation for IonQ stock at the time of sale, benefiting the reporting person.

Negatives

• The significant volume of shares sold by a key executive (Executive Chair and Director) could be perceived negatively by investors, potentially signaling a reduction in insider confidence or a desire for diversification.
• The reduction in direct beneficial ownership by a high-ranking insider may lead to questions about long-term commitment, despite the pre-planned nature of the sales.

Risks

• Market perception risk: Investors may interpret the large insider sale as a negative signal, potentially leading to downward pressure on the stock price.
• Reduced insider alignment: A decrease in the Executive Chair's direct equity stake could be seen as a slight reduction in alignment of interests with common shareholders, although a substantial number of options and shares are still held.

Future Outlook

This Form 4 filing reports past insider transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing details specific insider trading activity for IonQ, Inc. and does not provide broader insights into industry trends or competitive landscape. Insider transactions are common across all industries and are typically driven by individual financial planning, diversification, or liquidity needs.

Related Party Transactions

• The entire document details related party transactions, specifically the exercise of stock options and subsequent sale of common stock by Peter Hume Chapman, an Executive Chair and Director of IonQ, Inc. These transactions are considered related party dealings as they involve a company insider.

Stakeholder Impact

• Shareholders: May react to the significant insider selling, potentially leading to a negative perception or increased scrutiny of the stock, despite the pre-planned nature of the sales.
• Employees: No direct impact mentioned, but general market sentiment can indirectly affect employee morale or stock-based compensation value.

Next Steps

• No specific future actions, events, or milestones for the company are mentioned in this Form 4 filing, as it pertains solely to insider trading activity.

Key Dates

Keywords

IonQ, IONQ, Form 4, insider trading, stock sale, executive compensation, Peter Hume Chapman, Rule 10b5-1 plan, quantum computing